TPO-RAs Combining Anti-CD 20 Monoclonal Antibody Versus TPO-RAs in the Management of Pediatric Primary Immune Thrombocytopenia (ITP)
Clinical trial NCT05718856 · UNKNOWN
Trial details
- NCT number
- NCT05718856
- Sponsor
- Institute of Hematology & Blood Diseases Hospital, China
- Status
- UNKNOWN
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2023-02-23
- Primary completion
- 2025-05-14
- Enrollment
- 166
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.